Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
The widow of a man who died from kidney cancer after ingesting allegedly contaminated valsartan has filed a wrongful death action against the drug’s makers in Louisiana federal court, accusing them of knowing the drug was adulterated, yet touting its safety to doctors and consumers.
Issue #132, November 2018
A Colorado federal judge has dismissed without prejudice claims asserted against Olympus Medical Systems Corp. in a contaminated duodenoscope action, ruling that the court lacks personal jurisdiction over the company because it lacks the requisite minimum contacts with Colorado.
A Kentucky appellate court has upheld dismissal of a case involving a heart catheter, ruling that the claims against Biosense Webster Inc. are preempted because the plaintiff did not assert state law claims that are based upon violations that parallel federal regulations.
The Arizona federal judge overseeing the C.R. Bard IVC filter multidistrict litigation docket has removed the _Mulkey_ case from the bellwether trial schedule, explaining that another trial focusing on the Eclipse filter would be a waste of time and judicial resources.
A California appellate court has reinstated a lawsuit accusing the makers of four diabetes drugs of failing to warn of the risk of pancreatic cancer, ruling that the trial court should have considered newly discovered scientific evidence that the Food and Drug Administration had not previously evaluated in approving the drugs’ warning labels.
Four California residents have sued Gilead Sciences Inc., accusing it of failing to warn doctors that its tenofovir and tenofovir-based antiviral AIDS drugs Viread and Truvada can cause kidney failure and bone fractures.
The Massachusetts federal judge overseeing the Stryker LFIT CoCr V40 Femoral Heads hip implant multidistrict litigation has stayed the litigation pending finalization of a confidential settlement agreement.
A Washington state judge has imposed sanctions on Biomet Inc. in the form of attorneys’ fees for failing to comply with plaintiffs’ discovery requests in a Magnum hip replacement lawsuit.
A Missouri woman has sued Encore Medical L.P. d/b/a DJO Surgical, accusing it of failing to warn her surgeon that its hip system is prone to femoral stem disassociation and failing to adequately test the device before placing it on the market.
A Washington federal judge has dismissed with prejudice a lawsuit involving Allergan’s Natrelle breast implants, finding the claims are expressly preempted because they seek to impose safety requirements that are different from, or in addition to, those imposed by federal law.